Expression plasmids encoding EGFP-tagged Rab GTPases were prepared as described elsewhere with some modifications (1). Template cDNA was synthesized with a First Strand cDNA Synthesis Kit (GE Healthcare) using total RNA extracted from N2a-3 cells with TRIzol Reagent (Life Thechnologies). The cDNA fragments, which included the entire open reading frame of each of the following wild-type mouse genes (Rab4a, Rab5a, Rab7, Rab9, Rab11a and Rab22a), were amplified from the template cDNAs using the corresponding pair of oligonucleotide primers (Table S2) in Table S2 . The PCR products were cloned into pCRII-topo with TA Cloning Kit (Invitrogen). The cDNA fragments of a GTP-binding deficient dominant-negative mutant of each of six Rab GTPases, Rab4aS22N, Rab5aS34N, Rab7T22N, Rab9S21N, Rab11aS25N and Rab22aS19N (2-7), were produced by site-directed mutagenesis by overlap extension PCR (8) using mutagenic oligonucleotide primers (Table   S3 ). The resulting PCR products were cloned into pCR-BluntII-topo with Zero Blunt TOPO PCR Cloning Kit (Invitrogen). Thereafter, the cloned cDNA fragments encoding the wild-type Rab GTPase or a dominant-negative mutant were excised by digestion with Xho I and then cloned into the Xho I site of pEGFP-C1.
final concentration of 0.5%, and the homogenate was incubated for 30 min at 4˚C. Each sample was then adjusted to 26% OptiPrep (Axis-shield) in CBS and stepwise OptiPrep gradients were prepared by overlaying 23% and 8% OptiPrep in CBS, and CBS in an ultra-centrifugation tube (Beckman). The stepwise OptiPrep gradients were centrifuged at 18,000 rpm for 2 h at 4˚C using a SW32Ti rotor (Beckman). The lipid band at the 8%-23% interface was collected and mixed with 1/2 volume of 5 M NaCl, 0.15 M Tris-HCl (pH 8.0).
The sample was adjusted to 26% OptiPrep and stepwise OptiPrep gradients were prepared by overlaying 23% and 8% OptiPrep (in PBS), and PBS in an ultra-centrifugation tube. The gradient was centrifuged at 18,000 rpm for 2 h at 20˚C using a SW32Ti rotor. The lipid band at the 8%-23% interface was collected and adjusted to 2% sarkosyl and incubated with 25 units/ml Benzonase (Novagen) for 30 min at 37˚C. Each sample was then digested with 10 μg/ml of PK for 1 h at 37˚C, and the PK digestion was terminated by incubation with 100 μM Pefabloc SC (Roche) for 15 min at 4˚C. Each sample was adjusted to 30 mM EDTA, and thereafter, 1/1.8 volume of 5 M NaCl solution was mixed in to the sample. The sample was overlaid onto a sucrose pad solution [1 M sucrose, 0.1 M NaCl, 0.5% Zwittergent 3-14 (Calbiochem), and 10 mM Tris-HCl (pH 7.5)] in an ultracentrifuge tube and centrifuged at 32,000 rpm for 2 h at 20˚C using a SW32Ti rotor. The pellet was washed twice with 0.5% Zwittergent 3-14 in PBS followed by centrifugation at 64,000 rpm for 30 min at 20˚C using a S80AT3 rotor (Hitachi). The final pellet was resuspended in PBS containing 0.5% Zwittergent 3-14.
Co-localization statistics
Quantitative co-localization analysis was performed as described elsewhere (9) . The co-localization ratio of inoculated PrP-res with each organelle marker that represents a percentage of weighted co-localization coefficient was quantified using ZEN2009 software.
Briefly, the weighted co-localization coefficient was calculated using the following formula;
where PrPresi,col ocl represents the intensity of a pixel of inoculated PrP-res signal co-localized with an organelle marker, whereas, PrPresi,total represents the intensity of a pixel of inoculated PrP-res signal regardless of whether it co-localized with an organelle marker or not. was observed with the overexpression of wild-type Rab5a, Rab11a, or the dominant-negative Rab4a mutant, these tagged proteins did not influence the de novo generation of PrP Sc (Fig.   7 ).
Supplementary Video 1. Time-lapse image of Af555-22L-PrP-res in N2a-3 cells.
N2a-3 cells were incubated with Af555-22L-PrP-res for 6 h at 37˚C and then subjected to 
